Page last updated: 2024-08-21

metylperon and Psychoses

metylperon has been researched along with Psychoses in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedman, JH1
Jayathilake, K; Meltzer, HY; Sumiyoshi, T1
Hippius, H; Klages, U; Müller-Spahn, F1
Farde, L; Halldin, C; Wiesel, FA1
Christensen, I; Geismar, L; Kirkegaard, A; Kirkegaard, G1

Reviews

1 review(s) available for metylperon and Psychoses

ArticleYear
[Atypical neuroleptics, pharmacology and clinical importance].
    Fortschritte der Neurologie-Psychiatrie, 1993, Volume: 61, Issue:11

    Topics: Animals; Antipsychotic Agents; Brain; Butyrophenones; Clinical Trials as Topic; Clozapine; Humans; Psychotic Disorders; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin

1993

Trials

2 trial(s) available for metylperon and Psychoses

ArticleYear
Melperone is ineffective in treating Parkinson's disease psychosis.
    Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:6

    Topics: Antipsychotic Agents; Butyrophenones; Humans; Parkinson Disease; Psychotic Disorders; Treatment Failure

2012
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
    Schizophrenia research, 2003, Jan-01, Volume: 59, Issue:1

    Topics: Analysis of Variance; Antipsychotic Agents; Butyrophenones; Cognition; Female; Humans; Male; Multivariate Analysis; Psychotic Disorders; Regression Analysis; Schizophrenia

2003

Other Studies

2 other study(ies) available for metylperon and Psychoses

ArticleYear
Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
    Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 352

    Topics: Adult; Antipsychotic Agents; Butyrophenones; Female; Humans; Male; Prolactin; Psychotic Disorders; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Tomography, Emission-Computed

1989
Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Butyrophenones; Child; Child, Preschool; Dizziness; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Hypnotics and Sedatives; Infant; Male; Psychotic Disorders; Sialorrhea; Time Factors

1986